WuXi Biologics to build €325M biologics facility in Dundalk, Ireland

WuXi Biologics will invest €325 million to build a new biologics drug substance manufacturing facility in Dundalk, Ireland, creating 400 jobs over five years. The facility will use single-use bioreactors and is the company's first site outside China.

“WuXi Biologics is to invest €325 million and create 400 new jobs over five years in a new biologics drug substance manufacturing facility on the Industrial Development Authority’s (IDA) greenfield site in Mullagharlin, Dundalk, Co. Louth.”wuxibiologics.com

• 1 source
• wuxibiologics.comWuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Irelandgavin guoApr 30, 2018

Summarized from public sources; check the original articles before acting on it.